These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. The effect of pravastatin on prevention of restenosis after successful percutaneous transluminal coronary angioplasty. Onaka H; Hirota Y; Kita Y; Tsuji R; Ishii K; Ishimura T; Kawamura K Jpn Circ J; 1994 Feb; 58(2):100-6. PubMed ID: 8196151 [TBL] [Abstract][Full Text] [Related]
32. Prevention of restenosis after percutaneous transluminal coronary angioplasty by reducing lipoprotein (a) levels with low-density lipoprotein apheresis. Low-Density Lipoprotein Apheresis Angioplasty Restenosis Trial (L-ART) Group. Daida H; Lee YJ; Yokoi H; Kanoh T; Ishiwata S; Kato K; Nishikawa H; Takatsu F; Kato H; Kutsumi Y Am J Cardiol; 1994 Jun; 73(15):1037-40. PubMed ID: 8198026 [TBL] [Abstract][Full Text] [Related]
33. Angiotensin-converting enzyme inhibition with fosinopril sodium in the prevention of restenosis after coronary angioplasty. Desmet W; Vrolix M; De Scheerder I; Van Lierde J; Willems JL; Piessens J Circulation; 1994 Jan; 89(1):385-92. PubMed ID: 8281674 [TBL] [Abstract][Full Text] [Related]
34. Transoesophageal pacing echocardiography for detection of restenosis after percutaneous transluminal coronary angioplasty. Hoffmann R; Kleinhans E; Lambertz H; Flachskampf FA; Uebis R; Buell U; Hanrath P Eur Heart J; 1994 Jun; 15(6):823-31. PubMed ID: 8088272 [TBL] [Abstract][Full Text] [Related]
35. Effect of high dose verapamil on restenosis after peripheral angioplasty. Schweizer J; Kirch W; Koch R; Hellner G; Uhlmann K J Am Coll Cardiol; 1998 May; 31(6):1299-305. PubMed ID: 9581724 [TBL] [Abstract][Full Text] [Related]
36. Fish oils and low-molecular-weight heparin for the reduction of restenosis after percutaneous transluminal coronary angioplasty. The EMPAR Study. Cairns JA; Gill J; Morton B; Roberts R; Gent M; Hirsh J; Holder D; Finnie K; Marquis JF; Naqvi S; Cohen E Circulation; 1996 Oct; 94(7):1553-60. PubMed ID: 8840843 [TBL] [Abstract][Full Text] [Related]
37. Restenosis after successful percutaneous transluminal coronary angioplasty: the Montreal Heart Institute experience. Guiteras Val P; Bourassa MG; David PR; Bonan R; Crépeau J; Dyrda I; Lespérance J Am J Cardiol; 1987 Jul; 60(3):50B-55B. PubMed ID: 2956844 [TBL] [Abstract][Full Text] [Related]
38. Ischemia: reperfusion injury and restenosis after coronary angioplasty. Park JW; Braun P; Mertens S; Heinrich KW Ann N Y Acad Sci; 1992 Sep; 669():215-36. PubMed ID: 1444028 [TBL] [Abstract][Full Text] [Related]
39. N-3 fatty acids do not prevent restenosis after coronary angioplasty: results from the CART study. Coronary Angioplasty Restenosis Trial. Johansen O; Brekke M; Seljeflot I; Abdelnoor M; Arnesen H J Am Coll Cardiol; 1999 May; 33(6):1619-26. PubMed ID: 10334433 [TBL] [Abstract][Full Text] [Related]
40. Detection of restenosis after elective percutaneous transluminal coronary angioplasty using the exercise treadmill test. Bengtson JR; Mark DB; Honan MB; Rendall DS; Hinohara T; Stack RS; Hlatky MA; Califf RM; Lee KL; Pryor DB Am J Cardiol; 1990 Jan; 65(1):28-34. PubMed ID: 2294678 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]